Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review
Pleura and Peritoneum · 08.06.2023 · 8 (2) · 65-74
DOI: 10.1515/pp-2023-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pleura and Peritoneum, online erschienen am 01.05.2023. Verfasst von Lorena Martín-Román und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital, Dublin, Ireland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The Peritoneal Surface Oncology Group International (PSOGI) consensus subdivided pseudomyxoma peritonei (PMP) into four groups according to histopathological features. The aim of this paper is to report survival outcomes after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) from a national referral centre and to correlate the PSOGI classification with survival.
Methods
A retrospective study of a prospectively maintained database was performed. Consecutive patients treated with CRS + HIPEC for PMP of appendiceal origin were included (September-2013 to December-2021). Pathological features of the peritoneal disease were used to classify patients into the four groups proposed by PSOGI. Survival analysis was performed to evaluate the correlation of pathology on overall survival (OS) and disease-free survival (DFS).
Results
Overall, 104 patients were identified; 29.6 % were reclassified as acellular mucin (AM), 43.9 % as low-grade mucinous carcinoma peritonei (LGMCP), 22.4 % as high-grade MCP (HGMCP) and 4.1 % as HGMCP with signet ring cells (HGMCP-SRC). Median PCI and rate of optimal cytoreduction were 19 and 82.7 %, respectively. Median OS and DFS were not reached, 5-year OS and DFS were 88.6(SD 0.04) % and 61.6(SD 0.06) %, respectively. Log-Rank test revealed significant differences in terms of OS and DFS across the different histological subgroups (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital, Dublin, Ireland.
- Department of Pathology, Mater Misericordiae University Hospital, Dublin, Ireland.
- Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.
ORCID-Profile: Lorena Martín-Román
Zitieren
APA
Martín-Román, L., Hannan, E., Faraz Khan, M., Müller, A. S., Shields, C., Aird, J., Moran, B., & Mulsow, J. (2023). Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review. Pleura and Peritoneum, 8(2), 65-74. https://doi.org/10.1515/pp-2023-0001
Vancouver
Martín-Román L, Hannan E, Faraz Khan M, Müller AS, Shields C, Aird J, et al. Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review. Pleura and Peritoneum. 2023;8(2):65-74. doi:10.1515/pp-2023-0001
BibTeX
@article{MartnRomn2023,
author = {Martín-Román, Lorena and Hannan, Enda and Faraz Khan, Mohammad and Müller, Anna Sophia and Shields, Conor and Aird, John and Moran, Brendan and Mulsow, Jurgen},
title = {Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review},
journal = {Pleura and Peritoneum},
year = {2023},
volume = {8},
number = {2},
pages = {65--74},
doi = {10.1515/pp-2023-0001}
}
EUVIMED